Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer
Titel:
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer
Auteur:
Park, Yeon Hee Im, Seock-Ah Kim, Sung-Bae Sohn, Joo Hyuk Lee, Keun Seok Chae, Yee Soo Lee, Ki Hyeong Kim, Jee Hyun Im, Young-Hyuck Kim, Ji-Yeon Kim, Tae-Yong Lee, Kyung-Hun Ahn, Jin-Hee Kim, Gun Min Park, In Hae Lee, Soo Jung Han, Hye Sook Kim, Se Hyun Jung, Kyung Hae